Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma – Fred Hutch News Service
Fred Hutch News Service |
Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
Fred Hutch News Service Compared with chemotherapy, the only previously available treatment, the benefit of immunotherapy drugs for these patients now “is so blatantly, strikingly obvious,” said Dr. Paul Nghiem of the University of Washington and Fred Hutchinson Cancer … |
